Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Beam Therapeutics Inc. (BEAM)  
$17.01 0.21 (1.25%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 106,253,000
Market Cap: 1.81(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.54 - $34.09
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Beam Therapeutics is a biotechnology company. Co. has identified four development candidates to date: three from its ex vivo platform, with two candidates targeting hemoglobinopathies and one candidate targeting T-cell leukemia, and one from its in vivo platform targeting glycogen storage disease. BEAM-102 directly corrects the causative mutation in sickle cell disease by recreating a naturally-occurring normal human hemoglobin variant, HbG-Makassar. BEAM-201 is an anti-CD7, multiplex edited, allogeneic chimeric antigen receptor T cell development candidate for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 77,349 125,994 290,138 1,599,537
Total Sell Value $1,406,390 $2,827,115 $7,037,861 $46,809,426
Total People Sold 5 5 5 7
Total Sell Transactions 6 11 18 36
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 201
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Simon Amy Chief Medical Officer   •       –      –    2025-04-02 4 AS $17.73 $372,294 D/D (20,997) 65,742 -9%     
   Ciaramella Giuseppe President   •       –      –    2025-04-01 4 AS $18.35 $136,418 D/D (7,434) 190,216 -5%     
   Cavanagh Bethany J SVP, Finance and Treasurer   •       –      –    2025-04-01 4 AS $18.35 $55,330 D/D (3,015) 44,512 -5%     
   Simon Amy Chief Medical Officer   •       –      –    2025-04-01 4 AS $18.35 $175,542 D/D (9,566) 86,739 -5%     
   Bellon Christine Chief Legal Officer   •       –      –    2025-04-01 4 AS $18.35 $104,122 D/D (5,674) 117,294 -5%     
   Evans John M. CEO   •       •      –    2025-04-01 4 AS $18.35 $562,684 D/D (30,663) 986,249 -5%     
   Fmr Corp   –       –       •   2025-03-31 3 IO $0.00 $0 I/I 0 3,261,955 -14%     
   Evans John M. CEO   •       •      –    2025-03-31 4 A $0.00 $0 D/D 77,500 1,016,159     -
   Ciaramella Giuseppe President   •       –      –    2025-03-31 4 A $0.00 $0 D/D 35,000 197,650     -
   Cavanagh Bethany J SVP, Finance and Treasurer   •       –      –    2025-03-31 4 A $0.00 $0 D/D 10,000 47,527     -
   Simon Amy Chief Medical Officer   •       –      –    2025-03-31 4 A $0.00 $0 D/D 27,500 96,305     -
   Bellon Christine Chief Legal Officer   •       –      –    2025-03-31 4 A $0.00 $0 D/D 20,000 122,968     -
   Cavanagh Bethany J SVP, Finance and Treasurer   •       –      –    2025-02-18 4 AS $35.00 $220,045 D/D (6,287) 37,527 -50%     
   Bellon Christine Chief Legal Officer   •       –      –    2025-02-14 4 AS $34.00 $340,000 D/D (10,000) 102,968 -47%     
   Bellon Christine Chief Legal Officer   •       –      –    2025-02-14 4 OE $7.22 $72,200 D/D 10,000 112,968     -
   Evans John M. CEO   •       •      –    2025-01-30 4/A OE $0.67 $20,100 D/D 30,000 968,659     -
   Evans John M. CEO   •       •      –    2025-01-30 4 AS $26.75 $802,484 D/D (30,000) 908,659 -34%     
   Bellon Christine Chief Legal Officer   •       –      –    2025-01-02 4 AS $24.68 $30,628 D/D (1,241) 102,968 -30%     
   Cavanagh Bethany J SVP, Finance and Treasurer   •       –      –    2025-01-02 4 AS $24.68 $27,568 D/D (1,117) 43,814 -30%     
   Emany Sravan Kumar Chief Financial Officer   •       –      –    2024-12-31 4 A $0.00 $0 D/D 80,000 80,000     -
   Ciaramella Giuseppe President   •       –      –    2024-12-17 4 OE $0.67 $35,845 D/D 53,500 162,650     -
   Ciaramella Giuseppe President   •       –      –    2024-11-06 4 AS $26.36 $1,347,050 D/D (51,110) 109,150 -14%     
   Ciaramella Giuseppe President   •       –      –    2024-10-14 4 AS $26.27 $1,342,752 D/D (51,110) 160,260 12%     
   Ciaramella Giuseppe President   •       –      –    2024-10-14 4 OE $0.67 $83,594 D/D 41,754 211,370     -
   Bellon Christine Chief Legal Officer   •       –      –    2024-10-01 4 AS $23.48 $9,040 D/D (385) 104,209 15%     
  201 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us